TIMP3 and acute myeloid leukemia: The ability of TAPI-0, to inhibit the induction of CD16-down-regulation and cell depletion by AML cells raised the possibility that TIMP3 may play a role in the resistance of LTNK cells to AML cell-induced NKCAs.